Dr. John Campbell

Professor Colleen Aldous is a medical researcher in South Africa, her main work in addition to her own research is supervision of clinical doctors who are undertaking research. Link to original paper, https://www.researchgate.net/publication/378624193_Wheel_Replacing_Pyramid_Better_Paradigm_Representing_Totality_of_Evidence-Based_Medicine https://www.semanticscholar.org/paper/Wheel-Replacing-Pyramid%3A-Better-Paradigm-Totality-Aldous-Dancis/72f1d5b3bd735eae69de57de6f8588cb5819098a

Link to Dr Cohen's channel for more videos, https://www.youtube.com/@accidental_doctor_michael Link to video, https://www.youtube.com/watch?v=sDfVlgxLOJ0

Link to Dave, Independent Researcher Substack, https://biologyphenom.substack.com/p/scottish-covid-19-inquiry-impact-dbf March 2020 Paramedic stress https://www.covid19inquiry.scot/sites/default/files/ev-documents/sci-wt0354-000001.pdf Robert Pollock Toe tagging letter. Discussions around age group, 70+ initially, discussion of over 50s Tough times ahead, would be supported Implementation unclear, but caused stress and pressures Clinical Adviser Paramedic, worked as a frontline paramedic during the pandemic. Do Not Resuscitate (DNR) 26. There was reporting in the media of the "toe tagging" of patients by age group which is wording for "do not try too hard to resuscitate them" over a certain age. Scottish Ambulance Service employees received a letter by email on Thursday 26 March 2020 from the Health and Care Professions Council which stipulated to every registrant that they realised there would be difficult decisions to be made by healthcare professionals, but they would be given full support to make decisions out with normal protocols. 27. … ordinarily, efforts were made to try and resuscitate every single person that has a feasible chance of success. However, the Health and Care Professional Council basically indicated that if employees did not do that on these occasions to coincide with the government statement, then they would fully support employees for any challenges employees may face as healthcare professionals. 28. This was very frightening for workers who have family members in that age group and it caused a lot of concern and anxiety for people who were used to doing their best to preserve life. The process of resuscitation has evolved, and we have a high success rate. This did not go down well with members. In addition, there were discussions about rumours within meetings with the Scottish Ambulance Service that the government had a plan to reduce the age group to those over 50s if Covid levels reached their expected peak and the plan for over 70s did not result in a significant enough drop in medical demand, with ages dropping depending on numbers coming through hospital. 29. Staff morale was severely affected, as they were trained to preserve life, they were paid lifesavers but at the time, they were told to do the complete opposite. This terrified staff that they might have to do this against their normal training and their normal desire to help. This was not a process that anyone welcomed.

Late fetal development in the third trimester (weeks 28–40) is mainly about rapid growth, organ maturation, and preparation for life outside the womb. The brain undergoes rapid growth in size and complexity Development of gyri and sulci (folds) increases surface area Improved neural connections Sleep–wake cycles become more regular Eyes open and close; can respond to light Hearing is well developed → responds to sounds and voices Increased coordinated movements: Kicking, stretching, grasping Pain perception https://pmc.ncbi.nlm.nih.gov/articles/PMC10072285/#:~:text=Conversely%2C%20the%20American%20College%20of,1%2C%202%2C%2011). https://pubmed.ncbi.nlm.nih.gov/33048913/ Utilization of analgesia and anesthesia during fetal surgery began in the early 1980s, US anesthesiology and fetal therapy consensus statement in 2021 recommends administration of fetal anesthesia in all invasive maternal-fetal procedures. Lungs mature significantly Increased production of surfactant (reduces alveolar collapse) By ~34–36 weeks, lungs are usually capable of supporting breathing Practice breathing movements occur (though no air is inhaled) Heart is fully formed and functioning Circulation is adapted to fetal life (e.g., ductus arteriosus still open) Prepares for transition at birth when fetal shunts close Rapid weight gain (most of it occurs now) Fat deposition under the skin: Helps with temperature regulation after birth Skin becomes: Less wrinkled More opaque Lanugo (fine hair) begins to disappear Skin and Coverings Nails grow to fingertips Hair on the scalp becomes thicker Swallowing amniotic fluid regularly Meconium (first stool) accumulates in intestines Liver stores glycogen for energy after birth Transfer of maternal antibodies (IgG) increases: Provides passive immunity after birth Fetus often settles into a head-down (cephalic) position near term Size by Term (around 40 weeks) Weight: ~3–4 kg Length: ~48–52 cm Current UK law Continuation of the 24-week time limit and the 10-week limit on telemedicine, agreed by Parliament in 2022 during the COVID-19 pandemic New law Remove the threat of police investigation, arrest, or prison for women ending their own pregnancy New law applies regardless of gestational age MPs back decriminalisation of abortion https://www.bma.org.uk/news-and-opinion/mps-back-decriminalisation-of-abortion?utm_source=chatgpt.com (Regardless of gestational age)? BMA welcomes move it describes as ‘long overdue’ while maintaining issue is a healthcare matter (England Wales) A vote in Parliament on 17 June (2025) saw lawmakers endorse the NC One (New Clause one) amendment to the Crime and Policing Bill, which could see an end to the threat of criminal investigation and prosecution of women who choose to terminate their pregnancy. MPs vote 379 to 137 in favour of the amendment BMA medical ethics committee deputy chair ‘The passing of this amendment is a significant and long overdue step towards reforming antiquated abortion law in England and Wales…. ‘Beyond this bill we will continue to push for wider reform of abortion law – including campaigning for the removal of criminal sanctions for medical professionals involved in abortions as part of their clinical practice…. The UK-wide decriminalisation of abortion has been BMA policy since 2017. (46 minutes of backbench debate) https://www.telegraph.co.uk/politics/2026/03/25/mps-urge-mahmood-block-decriminalising-late-abortions/ Lords move to decriminalise abortion up to birth https://care.org.uk/news/2026/03/lords-move-to-decriminalise-abortion-up-to-birth 19th March 2026 Baroness Monckton tabled an amendment to the Bill in the Lords to remove the “radical proposal” which she said was passed in the Commons “without any evidence, scrutiny, public consultation or impact assessment”. She argued that decriminalisatio

Important issues of life and death. Thanks to Neil Oliver and the GB News team.

With pathologist, author and researcher Dr. Clare Craig. To order your copied of the books, Spiked: UK: https://www.amazon.co.uk/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 USA: https://www.amazon.com/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Canada: https://www.amazon.ca/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Australia: https://www.amazon.com.au/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Netherlands: https://www.amazon.com.be/Spiked-shot-dark-Covid-Autopsy/dp/1739344723 Expired: UK: https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707 USA: https://www.amazon.com/Expired-untold-Dr-Clare-Craig/dp/1739344707/ Canada: https://www.amazon.ca/Expired-untold-Dr-Clare-Craig/dp/1739344707/ Australia: https://www.amazon.com.au/Expired-untold-Dr-Clare-Craig/dp/1739344707/ Netherlands: https://www.amazon.com.be/Expired-untold-Dr-Clare-Craig/dp/1739344707

A Hearing with Dr. Anthony Fauci https://oversight.house.gov/hearing/a-hearing-with-dr-anthony-fauci/

MRNA vaccines and cancer https://www.oncotarget.com/article/28827/text Article investigates the potential association between modified mRNA (modRNA) COVID-19 vaccinations and the development of haematopoietic cancers. Censorship in science https://www.oncotarget.com/article/28829/text Only relentless determination gets dissenting data published in peer-reviewed journals https://panagispolykretis.substack.com/p/only-relentless-determination-gets Case Study Healthy, young, athletic woman who, developed acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma (LBL), following her second dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty®), (July 2021) Drugs and Total Body Irradiation (TBI) April, 2025, cell transplant from an unrelated donor. Part of an expanding body of literature documenting similar occurrences after modRNA vaccinations. 30 papers describe malignancies that developed in close temporal relationship with modRNA COVID-19 vaccinations. (Often just a few days) with 28 focusing on haemato-lymphoproliferative disorders. In lymphoma, 4 cases, four cases showed onset at the inoculation site, three cases manifested in draining lymph nodes Japan, leukaemia, breast, pancreatic, and lip/oral/ pharyngeal cancers increased significantly in 2022 https://pubmed.ncbi.nlm.nih.gov/38721172/ critical literature gap: the absence of population studies verifying cancer incidence by vaccination status in order to estimate the true cancer incidence or mortality increases following COVID-19 vaccination. https://pubmed.ncbi.nlm.nih.gov/38933341/ ‘technically pro-drug gene therapies encased in lipid nanoparticles (LNPs), rather than natural naked mRNA. Emerging evidence suggests that the biodistribution and persistence of modRNA, facilitated by lipid nanoparticles, can affect various tissues and organs, including the bone marrow and other blood-forming organs. Unfettered access through most tissues and organs, Notably, modRNA vaccines exhibit a particular affinity for the bone marrow, potentially influencing the immune system at multiple levels and, triggering both autoimmune disorders and neoplastic processes. By integrating clinical observations and current research, we aim to provide valuable insights into the potential carcinogenic outcomes associated with modRNA vaccination. Cancer causing Mechanisms Toxic spike protein Vaccine induced lasts for longer than natural spike A double proline that confers greater stability. Synthetic pseudouridines contained in the modRNA have shown mitochondrial toxicity It has been demonstrated that this modification can increase the likelihood of +1 ribosomal frameshifting during translation, resulting in the production of multiple peptide products with unexplored effects (This obviously poses serious safety concerns as only a single antigen was supposed to be encoded by the modRNA, not many undefined peptides with unknown antigenic and autoimmune potential.) LNPs exhibits intrinsic cytotoxicity. Presence of LNP-encapsulated DNA contamination originating from residual plasmid DNA DNA integration may include the risk of tumorigenisis if insertion reduces the activity of a tumour suppressor or increases the activity of an oncogene. Vaccine induced T-cell immunosuppression, impairing cancer surveillance Interaction between the S2 subunit of the spike protein and the oncosuppressor proteins p53, BRCA1, and BRCA2 The impairment in type I interferon (IFN) signalling Increased Transforming Growth Factor Beta (TGF-β) Production. Vaccine begins to accumulate rapidly, particularly in the bone marrow, between 30 minutes and 48 hours following intramuscular injection, the concentration of radioactively labelled nanoparticles in the femoral bone marrow of rats increased by 7.9-fold. Proposed vaccine-i

Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) https://news.modernatx.com/news/news-details/2024/Moderna-Receives-U.S.-FDA-Approval-for-RSV-Vaccine-mRESVIAR/default.aspx May 31, 2024 Moderna, today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The approval was granted under a breakthrough therapy designation and marks the second approved mRNA product from Moderna. Stéphane Bancel, Chief Executive Officer of Moderna. The FDA approval of our second product, mRESVIA, builds on the strength and versatility of our mRNA platform Moderna expects to have mRESVIA available for eligible populations in the U.S. by the 2024/2025 respiratory virus season. Moderna has filed for mRNA-1345 approval with regulators in multiple markets around the world. https://www.clinicaltrialsarena.com/news/moderna-races-ahead-in-flu-and-covid-19-combo-vaccine-race-with-phase-iii-win/ Moderna races ahead in flu and Covid-19 combo vaccine race with Phase III win Moderna injection mRNA-1083 Comprises a seasonal influenza vaccine candidate, mRNA-1010, and a next-generation Covid-19 vaccine prospect called mRNA-1283. Moderna announces positive data from a Phase III trial of its mRNA vaccine candidate. Now, in a Phase III trial (NCT06097273) for mRNA-1083 Moderna “statistically significantly higher immune responses” compared to existing vaccines on the market. The trial met its primary endpoints, Moderna said in a 10 June press release. Immune response was seen across three influenza virus strains (H1N1, H3N2, and B/Victoria) and against SARS-CoV-2. Although Moderna has not published the full dataset from the Phase III trial, it plans to present the results in more detail at an upcoming medical conference, in addition to a submission for publication. The company said it “will engage with regulators on next steps”. Other mRNA vaccines in development Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials https://news.modernatx.com/news/news-details/2024/Moderna-Advances-Multiple-Vaccine-Programs-to-Late-Stage-Clinical-Trials/default.aspx Cytomegalovirus (CMV) CMVictory is a pivotal Phase 3 trial evaluating mRNA-1647 against primary CMV infection in women 16 to 40 years of age. Epstein-Barr virus (EBV) mRNA-1189 The randomized, observer-blind, placebo-controlled study is fully enrolled. Herpes simplex virus (HSV) mRNA-1608 Phase 1/2 trial The randomized 1:1:1:1, observer-blind, controlled study is fully enrolled with 300 participants in the U.S. Varicella-Zoster virus (VZV) Moderna's VZV vaccine candidate mRNA-1468 has initial data available from a Phase 1/2 trial Norovirus The Company is advancing mRNA-1403 toward a pivotal Phase 3 trial.

Censorship in science https://www.oncotarget.com/article/28829/text Only relentless determination gets dissenting data published in peer-reviewed journals https://panagispolykretis.substack.com/p/only-relentless-determination-gets MRNA vaccines and cancer https://www.oncotarget.com/article/28827/text Article investigates the potential association between modified mRNA (modRNA) COVID-19 vaccinations and the development of haematopoietic cancers. Case Study Healthy, young, athletic woman who, developed acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma (LBL), following her second dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty®), (July 2021) Drugs and Total Body Irradiation (TBI) April, 2025, cell transplant from an unrelated donor. Part of an expanding body of literature documenting similar occurrences after modRNA vaccinations. 30 papers describe malignancies that developed in close temporal relationship with modRNA COVID-19 vaccinations. (Often just a few days) with 28 focusing on haemato-lymphoproliferative disorders. In lymphoma, 4 cases, four cases showed onset at the inoculation site, three cases manifested in draining lymph nodes Japan, leukaemia, breast, pancreatic, and lip/oral/ pharyngeal cancers increased significantly in 2022 https://pubmed.ncbi.nlm.nih.gov/38721172/ critical literature gap: the absence of population studies verifying cancer incidence by vaccination status in order to estimate the true cancer incidence or mortality increases following COVID-19 vaccination. https://pubmed.ncbi.nlm.nih.gov/38933341/ ‘technically pro-drug gene therapies encased in lipid nanoparticles (LNPs), rather than natural naked mRNA. Emerging evidence suggests that the biodistribution and persistence of modRNA, facilitated by lipid nanoparticles, can affect various tissues and organs, including the bone marrow and other blood-forming organs. Unfettered access through most tissues and organs, Notably, modRNA vaccines exhibit a particular affinity for the bone marrow, potentially influencing the immune system at multiple levels and, triggering both autoimmune disorders and neoplastic processes. By integrating clinical observations and current research, we aim to provide valuable insights into the potential carcinogenic outcomes associated with modRNA vaccination. Cancer causing Mechanisms Toxic spike protein Vaccine induced lasts for longer than natural spike A double proline that confers greater stability. Synthetic pseudouridines contained in the modRNA have shown mitochondrial toxicity It has been demonstrated that this modification can increase the likelihood of +1 ribosomal frameshifting during translation, resulting in the production of multiple peptide products with unexplored effects (This obviously poses serious safety concerns as only a single antigen was supposed to be encoded by the modRNA, not many undefined peptides with unknown antigenic and autoimmune potential.) LNPs exhibits intrinsic cytotoxicity. Presence of LNP-encapsulated DNA contamination originating from residual plasmid DNA DNA integration may include the risk of tumorigenisis if insertion reduces the activity of a tumour suppressor or increases the activity of an oncogene. Vaccine induced T-cell immunosuppression, impairing cancer surveillance Interaction between the S2 subunit of the spike protein and the oncosuppressor proteins p53, BRCA1, and BRCA2 The impairment in type I interferon (IFN) signalling Increased Transforming Growth Factor Beta (TGF-β) Production. Vaccine begins to accumulate rapidly, particularly in the bone marrow, between 30 minutes and 48 hours following intramuscular injection, the concentration of radioactively labelled nanoparticles in the femoral bone marrow of rats increased by 7.9-fold. Proposed vaccine-in

Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ Inside mRNA vaccines https://www.insidemrnavaccines.com/ Filmmaker: Erik Tangsoo Inside the Vaccine Trials https://www.youtube.com/watch?v=tBhjCBa7oDE Inside the vaccine trials https://www.vaccinetrialstories.com/

Full summary in the first few minutes of this video, its good news examination of the 166 patients admitted since the Omicron variant arrived snapshot of the clinical profile of 42 patients currently in the COVID wards at SB The majority of hospital admissions are for diagnoses unrelated to COVID-19. The SARS-CoV-2 positivity is an incidental finding in these patients and is largely driven by hospital policy requiring testing of all patients requiring admission to the hospital. 76% of patients are incidental COVID admissions. This very unusual picture is also occurring at other hospitals in Gauteng. The high proportion of COVID incidental admissions may reflect higher rates of community transmission compared to previous waves (variants) that is not translating into higher admission rates for a primary COVID-19 diagnosis. Tshwane District Omicron Variant Patient Profile - Early Features 4th December https://www.samrc.ac.za/news/tshwane-district-omicron-variant-patient-profile-early-features There has been a significant rise in new SARS-CoV-2 infections in the Gauteng Province in the last four weeks which has been attributed to Omicron variant announced on 24 November 2021 The first cases of Omicron were detected in the Tshwane District The City of Tshwane Metropolitan Municipality is the metropolitan municipality that forms the local government of northern Gauteng Province, South Africa The Metropolitan area is centred on the city of Pretoria with surrounding towns and localities population of 2,708,702 people This is where the 4th wave started Tshwane has been the global epicentre of the Omicron Outbreak cases rising exponentially over several weeks 41,921 cases by 3 December 29 November to 3 December 2021 Cases + 9,929 reported in Tshwane Steve Biko/Tshwane District Hospital Complex in Pretoria in the heart of the Tshwane District statistics presented by the Gauteng Department of Health on 2 December 2021 for the province as a whole, and with admissions across all public and private hospitals in Tshwane we have seen a sharp rise in admissions Between 14th and 29th November 2021 166 new admissions Patient information presented here only represents the first two weeks of the Omicron wave in Tshwane The clinical profile of admitted patients could change significantly over the next two weeks, by which time we can draw conclusions about the severity of disease with greater precision. The main observation that we have made over the last two weeks is that the majority of patients in the COVID wards have not been oxygen dependent. SARS-CoV-2 has been an incidental finding in patients that were admitted to the hospital for another medical, surgical or obstetric reason. A snapshot of 42 patients in the ward on 2 December 29 (70%) are not oxygen dependent These patients are saturating well on room air, and do not present with any respiratory symptoms. ‘incidental COVID admissions’ having had another medical or surgical reason for admission. Thirteen (13) patients are dependent on supplemental oxygen of which nine (21%) have a diagnosis of COVID-19 pneumonia All are being prescribed steroids as the mainstay of therapy. The remaining 4 patients are on oxygen for other medical reasons This is a picture that has not been seen in previous waves. Past 3 waves only been a sprinkling of patients on room air in the COVID ward The numbers of patients in high care on double oxygen, High Flow Nasal Oxygen or non-invasive ventilation (NIV) were noticeably higher in previous waves. This is anecdotal but confirmed by numerous clinicians who have previously worked in the COVID wards in the hospital complex. Of 38 adults in the COVID wards on 2 December 6 were vaccinated 24 were unvaccinated 8 had unknown vaccination status Of 9 patients with COVID pneumonia 8 are unvaccinated 1 is a

Important statement from Dr. Joseph Fraiman, physician and clinical scientist. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults https://twitter.com/JosephFraiman https://pubmed.ncbi.nlm.nih.gov/36055877/ My interview with Dr. Fraiman https://www.youtube.com/watch?v=vsh5xNjc1Fs

Covid antibodies found in stored blood samples Milan Institute for Tumour Diseases, Coronavirus antibodies, September, 2019 Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy (October 2021) https://pubmed.ncbi.nlm.nih.gov/33176598/ Full text version https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529295/ Screening and Multiple Intervention on Lung Epidemics (SMILE https://clinicaltrials.gov/ct2/show/NCT03654105 There are no robust data, coronavirus 2 (SARS-CoV-2) infection and spread, prepandemic period worldwide We investigated the presence of SARS-CoV-2 receptor-binding domain (RBD)-specific antibodies Blood samples of 959 asymptomatic individuals, enrolled in a prospective lung cancer screening trial, between September 2019 and March 2020 Plasma samples repository Results SARS-CoV-2 RBD-specific antibodies were detected in, 111 of 959 (11.6%) individuals All the patients were asymptomatic at the time of blood sample collection. Actual timeframe First positive test, 3rd September September 2019 23/162 (14.2%) October 2019 27/166 (16.3%) Second week of February 2020, (more than 30%) By the end of September, Lombardy, Veneto, Piedmont, Emilia Romagna, Liguria, Lazio, Campania, Friuli. Official timeframe End of December 2019, coronavirus 2 identified in Wuhan, Hubei Province, China January 30th 2020 Italy’s first two cases, (two tourists from China tested positive in Rome) February 20, 2020 Lombardy, 38-year-old man, no history of travel Authors This study shows an unexpected very early circulation of SARS-CoV-2 among asymptomatic individuals Several months before the first patient was identified Finding SARS-CoV-2 antibodies in asymptomatic people before the COVID-19 outbreak in Italy may reshape the history of pandemic. Phenomena 1 Underestimation of prevalence Swabs and serology, focused on symptomatic cases Therefore, an underestimation of overall COVID-19 infections (Selection bias) Therefore overestimation of mortality rate May 25 and July 15 (2020) SARS-CoV-2 seroprevalence study, n = 64,660 Prevalence rate was 2.5% Approximately 1.5 million, (many of whom were asymptomatic) Estimate almost 5 times higher than official reports Phenomena 2 Onset of the epidemic, likely to have preceded identification of the first case November–December 2019 Doctors reporting, severe respiratory symptoms in elderly and frail, with atypical bilateral bronchitis, which was attributed to aggressive forms of seasonal influenza Based on these findings, a prior unnoticed circulation of the virus among the Italian population could be hypothesized. October 2019 to February 2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428442/ Molecular analysis, PCR, 40 wastewater samples Milan/Lombardy, Turin/Piedmont, and Bologna/Emilia Romagna) Presence of viral RNA, December 18th in Milan and Turin So, in which direction did the virus travel? 7th Military World Games 第七届世界军人运动会 Commonly known as Wuhan 2019 October 18–27, 2019 Around 230,000 volunteers 9,308 athletes from 109 countries competing in 329 events

This excellent scientific analysis of recent events continues in interview three of this series. Follow Dr. Craig on SubStack, https://drclarecraig.substack.com COVID, the untold story. So much more makes sense after this book and my first illuminating discussion with Dr. Craig. Get your copy in the UK here: https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707 For friends in the US get your copy here, https://www.amazon.com/Expired-untold-Dr-Clare-Craig/dp/1739344707 Have you ever felt the covid story did not entirely add up? Expired contains multiple eye-opening revelations about covid with compelling evidence that provides a coherent, sober and clear explanation that better fits the data we have so far. Meticulous research by pathologist Dr Clare Craig sheds light on the largely overlooked evidence of airborne virus transmission, examining twelve related beliefs on spread, lockdowns, asymptomatic infections, and masks. In addition, Expired champions the importance of Western ethical principles, damaged by pandemic actions and calls for their restoration. The covid debate has proved incredibly polarising. One side believed every intervention was saving lives, while the other emphasised the harms caused. Biased modelling based on a worst-case scenario led to fearful assumptions presented as fact. By dint of sheer repetition these ‘facts’ became unquestionable. Those scientists who dared to question were proclaimed dangerous. Welcome to Cloud-Covid-Land. Let’s bring back nuance. It’s time to return to reality."

Cases of omicron doubling every 2 to 3 days in UK Sajid Javid, Community transmission of Omicron https://www.bbc.co.uk/news/uk-59553460 Multiple regions of England with no links to international travel 21 Omicron cases in England linked to travel from Nigeria Cases + 90 = 336 confirmed No hospital admissions Could not guarantee omicron would not knock us off our road to recovery Incubation period may be shorter So a person will become infectious sooner Omicron to become dominant in the next few weeks UK response 10,000 vaccinators were being recruited 450 military Pre-departure tests Red lists Masks in shops and public transport Omicron case contacts required to self-isolate for 10 days, regardless of vaccine status UK Health Security Agency, 500,000 tests per day Dominic Raab https://www.bbc.co.uk/news/live/59559623 Plan B. not required because of success of the vaccination programme. Government is taking, targeted and proportionate approach Denmark https://www.nytimes.com/2021/12/05/world/europe/britain-denmark-omicron-cases.html Omicron, 183 confirmed on Sunday Triple the Friday estimate Henrik Ullum, Danish Statens Serum Institut The time we gain, we must use to get as many people vaccinated as possible And the shots will be aspirated (JC) Dr Jeffrey Barrett, director Covid-19 genomics initiative, Wellcome Sanger Institute Omicron spreading faster than Delta UK's dominant variant within a matter of weeks It is too early to make this assumption (on severity) If only a small proportion of people get seriously ill with Omicron, a small faction of a really big number can still cause problems Prof Paul Hunter New variant could be spreading faster than the currently dominant Delta variant, would probably start to overtake Delta within the next few weeks Prof Tim Spector UK omicron, probably at least 1,000 to 2,000 New variant can only be picked up by 30-40% of PCR tests Symptoms from Omicron appear at the moment more similar to a cold, rather than the classic Covid symptoms of a high temperature, a new, continuous cough or a loss of sense of taste or smell This means many cases may be missed Omicron cases are expected to double around every two days Anthony Fauci on omicron https://www.dw.com/en/coronavirus-digest-us-expert-fauci-cautiously-optimistic-over-omicron-reports/a-60029060 Thus far, it does not look like there's a great degree of severity to the omicron variant But we have really got to be careful before we make any determinations that it is less severe or it really doesn't cause any severe illness, comparable to delta Mayor Bill de Blasio (NY) https://www.bbc.co.uk/news/business-59552524 All New Yorkers will need to be vaccinated if they want to go to work Public sector employers already Mandate will now be extended to all private sector employees From 27th December, 184,000 businesses Omicron (10 cases so far) Holiday gatherings Cold weather Should be assumed, already community spread in New York Already mandating Morgan Stanley, Blackrock and Goldman Sachs, McDonald's, Walgreens, Walmart President Cyril Ramaphosa, SA We are experiencing a rate of infections that we have not seen since the pandemic started Argentina First case on Sunday Also Brazil, Mexico, Chile Russia First confirmed cases on Monday Ten people tested positive returning from SA Two had omicron variant Asia Thailand, Nepal, first cases on Monday India Up to 21 cases

Thanks to film maker Erik Tangsoo for his brilliant graphics. Do check out his full film here, Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ Inside the Vaccine Trials https://www.youtube.com/watch?v=tBhjCBa7oDE

UK parliament and EU Parliament ONS, 1st November release, UK deaths, week ending 21 October 2022 13,463 15.7% 1,822 excess deaths Deaths involving COVID-19, 5.5% of all UK deaths https://www.bhf.org.uk/-/media/files/what-we-do/influencing-change/tipping-point-bhf-report.pdf?rev=089147572a2c4dd789746b5e6f4ba617&hash=F7141D4C13A10C6C089824892CA59CDE https://hansard.parliament.uk/commons/2022-10-24/debates/FF880636-BC3B-4BDB-A5E0-D6D4B82B2888/Covid-19VaccinesSafety Mr. Andrew Bridgen MP (NW Leicestershire) https://www.youtube.com/watch?v=pfgGCgxGYkk Eurostat https://ec.europa.eu/eurostat/databrowser/view/demo_mexrt/default/table?lang=en https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:Map01_Excess_Mortality_2022_Aug.png

Health Secretary urged to release data that ‘may link Covid vaccine to excess deaths’ MPs and peers criticise ‘wall of silence’ Tweet from Andrew Bridgen with the letter in full https://twitter.com/ABridgen Health Secretary urged to release data that ‘may link Covid vaccine to excess deaths’ MPs and peers criticise ‘wall of silence’ https://www.telegraph.co.uk/news/2024/03/02/health-secretary-release-data-covid-vaccine-excess-deaths/ MPs and peers have accused the Health Secretary of withholding data that could link the Covid vaccine to excess deaths A cross-party group “growing public and professional concerns” UK’s rates of excess deaths since 2020 Demand to be shown the underlying data for to support the Government’s assertion, “no evidence” linking excess deaths to the vaccines for Covid-19. 21 MPs and peers “If those data do indeed exist, please share them; if thorough investigations have already ruled out such a link, please share the relevant reports,” “There is no place here for blind faith.” Written to Health Secretary Department of Health and Social Care (DHSC) Medicines and Healthcare products Regulatory Agency (MHRA) UK Health Security Agency (UKHSA) Potentially critical data, which maps the date of people’s Covid vaccine doses to the date of their deaths, have been released to pharmaceutical companies but not put into the public domain. Data should be released “on the same anonymised basis that it was shared with the pharmaceutical groups, and there seems to be no credible reason why that should not be done immediately”. “Questions about these trends, however, have to date been met by a relative wall of silence from your organisations and other public health officials.” A DHSC spokesman “We are committed to data transparency and publish a wide range of data on excess mortality. The datasets published are kept under constant review.”

Making videos, aspirating before injecting, vitamin D and Omicron. Messages to get out there, thank you Mr. Afshin Rattansi, for taking on the topics often ignored by MSM. Link to original video, https://www.youtube.com/watch?v=emG-oMEWlB4

Link to but the book, https://covidthroughoureyes.com.au/products/covid-through-our-eyes-an-australian-story-of-mistakes-mistreatment-and-misinformation Letters from Australia is Alison Bevege's Substack, https://lettersfromaustralia.substack.com/

Covid infection did not increase incidence of post-covid myocarditis or pericarditis. The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients-A Large Population-Based Study https://pubmed.ncbi.nlm.nih.gov/35456309/ https://www.mdpi.com/journal/jcm Myocarditis and pericarditis, post-acute cardiac sequelae of COVID-19 infection, arising from adaptive immune responses. ? incidence Retrospective cohort study Study group, had infection N = 196,992 adults after COVID-19 infection (Clalit Health Services) March 2020 to January 2021 Inpatient myocarditis and pericarditis diagnoses, from day 10 after positive PCR Israeli vaccination program initiated on 20 December 2020 Follow-up was censored on 28 February 2021 Control cohort, never infected N = 590,976 adults, with at least one negative PCR and no positive PCR (age- and sex-matched) Calculated backward from 15 December 2020 Results Post-COVID-19 group Nine post-COVID-19 patients developed myocarditis (0.0046%) Eleven diagnosed with pericarditis (0.0056%) Control group, never covid infected 27 developed myocarditis (0.0046%) P = 1 52 developed pericarditis (0.0088%) P = 0.17 Adjusted hazard ratio [aHR] Myocarditis, male (aHR 4.42) regardless of previous COVID-19 infection Pericarditis, (aHR 1.93) Peripheral vascular disease, (aHR 4.20) Follow up Median, 4.1 months Covid cohort, 700,040 person-months Non covid cohort, 2,100,077 person-months Conclusions Post COVID-19 infection was not associated with myocarditis (aHR 1.08) Post COVID-19 infection was not associated with pericarditis (aHR 0.53) We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection. Our data suggest that there is no increase in the incidence of myocarditis and pericarditis in COVID-19 recovered patients, compared to uninfected matched controls.

This excellent scientific analysis of recent events continues in interview three of this series. Follow Dr. Craig on SubStack, https://drclarecraig.substack.com COVID, the untold story. So much more makes sense after this book and my first illuminating discussion with Dr. Craig. Get your copy in the UK here: https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707 For friends in the US get your copy here, https://www.amazon.com/Expired-untold-Dr-Clare-Craig/dp/1739344707 Have you ever felt the covid story did not entirely add up? Expired contains multiple eye-opening revelations about covid with compelling evidence that provides a coherent, sober and clear explanation that better fits the data we have so far. Meticulous research by pathologist Dr Clare Craig sheds light on the largely overlooked evidence of airborne virus transmission, examining twelve related beliefs on spread, lockdowns, asymptomatic infections, and masks. In addition, Expired champions the importance of Western ethical principles, damaged by pandemic actions and calls for their restoration. The covid debate has proved incredibly polarising. One side believed every intervention was saving lives, while the other emphasised the harms caused. Biased modelling based on a worst-case scenario led to fearful assumptions presented as fact. By dint of sheer repetition these ‘facts’ became unquestionable. Those scientists who dared to question were proclaimed dangerous. Welcome to Cloud-Covid-Land. Let’s bring back nuance. It’s time to return to reality."

Dr. Clare Craig (doctor, pathologist, author, researcher). Excellent text on the pandemic, hard copy, Kindle and audio, https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707/ref=sr_1_1?crid=3E93FOWVOC0XX&dib=eyJ2IjoiMSJ9.JFeEViLIDz8rNi6E0HczPLFg-Rhhp0fkaEuFRtYftjRIDahju5qw8l9fofi8C2bD.CDOKUrBi_LzAdqysyTNwiaxvbEegCknK7-KFf6ouAdQ&dib_tag=se&keywords=expired+craig&qid=1758968302&sprefix=expired+craig%2Caps%2C129&sr=8-1 Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ Inside mRNA vaccines https://www.insidemrnavaccines.com/ Filmmaker: Erik Tangsoo Inside the Vaccine Trials https://www.youtube.com/watch?v=tBhjCBa7oDE Inside the vaccine trials https://www.vaccinetrialstories.com/

Link for free download of John's two text books, http://159.69.48.3/ Campbell's Pathophysiology Notes, Amazon orders for the UK, https://www.amazon.co.uk/dp/B012HWC8SU/ref=cm_sw_em_r_mt_dp_AYC5Q7G3H2B3T4BCHQY0 Campbell's Physiology Notes https://www.amazon.co.uk/dp/0955379725/ref=cm_sw_em_r_mt_dp_K0MXMAP26Y77TY4J90FB Omicron, clinical picture (7th December) Dr Angelique Coetzee, South African Medical Association First to raise alarm about the new omicron https://www.youtube.com/watch?v=BtELl7-zE_w Totally different symptoms Can be easily missed Body aches and pains Muscle pains Headache Tiredness (1 to 2 days) Slight sore throat No severe cough No runny nose Decrease in patients coming to doctors South Africa vaccines Pfizer J and J Hospitalizations, 99% unvaccinated Symptoms more intense in unvaccinated More intense but not severe Body aches and pains Muscle pains Headache Lateral flow testing and Omicron Becomes positive after 24 hours up to 5 days Very accurate Omicron prevalence in SA https://www.nicd.ac.za Ref for graphics (3rd December data) https://www.nicd.ac.za/wp-content/uploads/2021/12/Update-of-SA-sequencing-data-from-GISAID-3-Dec-21-Final.pdf SGTF has increased from 0.9% in October to 96.3% for November. Children under the age of 12 years accounted for 7.9% of the SGTF positives, and those 13 – 18 years old for 6.1%. For week 47, Hospital data from SA https://www.nicd.ac.za/wp-content/uploads/2021/12/NICD-COVID-19-Daily-Sentinel-Hospital-Surveillance-report-National-20211206.pdf Live data, hospital patients who have tested positive https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ Omicron and common cold https://osf.io/f7txy/ Omicron has insertion mutation ins214EPE (From the common cold, HCoV-229E coronavirus) Could have been acquired by switching Involving the genomes of other viruses that infect the same host cells as SARS-CoV-2 It is plausible that the Omicron insertion could have evolved in a co-infected individual PFIZER AND BIONTECH PROVIDE UPDATE ON OMICRON VARIANT https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage), while two doses show significantly reduced neutralization titers Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022

WHO and YT https://www.who.int/teams/digital-health-and-innovation/digital-channels/combatting-misinformation-online WHO works with social media policy departments to ensure company policy and guidelines for content providers are fit for purpose. John’s e mail [email protected] https://www.who.int/campaigns/connecting-the-world-to-combat-coronavirus/how-to-report-misinformation-online WHO provide a helpful guide on how to report misinformation online Inaccurate information spreads widely and at speed, making it more difficult for the public to identify verified facts and advice from trusted sources, such as their local health authority or WHO. https://support.google.com/youtube/answer/9795167?hl=en As a starting point in the UK, only NHS organisations are being invited to self-certify against the NHS Standard for Creating Health Content. By completing the self-certification process, an NHS organisation channel will be eligible for information panels indicating NHS credibility. From FDA to MHRA: are drug regulators for hire? https://www.bmj.com/content/377/bmj.o1538.full Regulatory agencies, large proportions of their budgets, funded by the industry they are sworn to regulate US Food and Drug Administration (FDA) 1992, Prescription Drug User Fee Act, allowing industry to fund the US Food and Drug Administration (FDA) directly through “user fees” Net PDUFA fees collected $29m in 1993 $884m in 2016 (65% of budget) FDA, 9 out of 10 of its past commissioners between 2006 and 2019 went on to secure roles linked with pharmaceutical companies European Medicines Agency (EMA) Industry fees funded 20% European Medicines Agency (EMA), in 1995 By 2010, 75% Today, 89% Medicines and Healthcare Products Regulatory Agency (MHRA) 86% of funding from Pharmaceutical Industry Australia https://www.tga.gov.au Proportion of TGA budget derived from industry, 96% WHO funding https://app.powerbi.com/view?r=eyJrIjoiNzNmNTRkMWEtNmZjMS00NzdjLWEyMDYtYWExYzA4NzVhZGQwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9 https://www.weforum.org/agenda/2020/04/who-funds-world-health-organization-un-coronavirus-pandemic-covid-trump/ The second-largest funder is the Bill and Melinda Gates Foundation, which provides 9.8% of the WHO's funds Appendix https://genius.com/George-orwell-nineteen-eighty-four-appendix-the-principles-of-newspeak-annotated https://www.orwell.ru/library/novels/1984/english/en_app It was expected that Newspeak would have finally superseded Oldspeak (or Standard English, as we should call it) by about the year 2050 The purpose of Newspeak was not only to provide a medium of expression for the world-view and mental habits proper to the devotees of Ingsoc, but to make all other modes of thought impossible. The C vocabulary was supplementary to the others and consisted entirely of scientific and technical terms. These resembled the scientific terms in use today, and were constructed from the same roots, but the usual care was taken to define them rigidly and strip them of undesirable meanings. War is peace, freedom is slavery, ignorance is strength Next Monday, 14th November, evidence based medicine confrence https://www.eventbrite.co.uk/e/has-big-pharma-hijacked-evidence-based-medicine-tickets-444525075467

To be reported to the UK police. Read the full letter here, https://twitter.com/JimFergusonUK/status/1765289139677618585/photo/1

Link to free download of my 2 textbooks http://159.69.48.3/ Louise Restaurant and Bar, night of 26th November https://www.telegraph.co.uk/world-news/2021/12/07/europes-biggest-omicron-outbreak-appears-mild-say-norway-covid/ Oslo, Norway, Christmas party Scatec solar power company One or two returned traveller Had returned days earlier 120 people (all double vaccinated) Mingled with outside groups later 70 of the 120 plus 50 others tested positive Half tested positive for omicron 13 proven in sequencing Dr. Tine Ravlo, Oslo, infectious diseases They have symptoms like fever, cough, headache, muscle pain, fatigue, but for now none of them have become severely ill and none of them have been treated in hospital The next day, one of two employees, recently returned from South Africa tested positive Norway's state epidemiologist, Frode Forland Sheer number of people infected at a single event, omicron considerably more infectious than delta Prof Forland, Norwegian Institute of Public Health One of three scenarios for omicron, it would be both very mild and very transmissible That is the hope That is the best scenario we can have That it's getting minder, most people will get it, and they will get a natural immunity It might be that it has now replicated and mutated so many times, that this is the optimal position from the virus' point of view, to spread widely and not kill the hosts That's what we've seen with other diseases beforehand. And of course, then it gets into more like an endemic phase Now this is not the end Nor is it the end of the beginning Rather it is the beginning of the end Sally I've had Delta, this time last year (pretty rough, took 6 months to fully recover) and I have Omicron now. The symptoms of Omicron are as you state. I am vaccinated. Helgard Living in SA (Gauteng) and have tested (+) 2 days ago, The symptoms is 100% correct as stated. Also after 1st symptoms, 3 days after i don't even know that i was sick. Body and muscle aches and pains Headache Tiredness (1 to 2 days) Slight sore throat No severe cough No runny nose Graph refs https://ourworldindata.org/coronavirus SA. Live data, hospital patients who have tested positive https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ South Africa references https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/sars-cov-2-genomic-surveillance-update/ Weekly deaths in SA https://www.samrc.ac.za/reports/report-weekly-deaths-south-africa Variants in SA https://www.worldometers.info/coronavirus/country/south-africa/ Sir Patrick Vallance from pandemic to endemic where this becomes a more regular infection like flu over time This virus has mutated a lot, quickly and that is sort of what you would expect at this stage the good news is that, so far, it looks as though when you get very high antibody levels with the booster vaccine it's definitely having some effect against it in the laboratory studies Boris Johnson Work-from-home from Monday Facemasks will be enforced in public venues Covid passes mandatory for nightclubs Daily testing instead of isolation for omicron contacts First plant-based coronavirus vaccine CoVLP (20 years of R and D) https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-announce-positive-phase-3-efficacy-and-safety-results/ GlaxoSmithKline and Medicago Primary endpoints and secondary endpoints met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3% efficacy against COVID-19 of any severity caused by Delta variant Vaccine candidate was well-tolerated, with no related serious adverse events reported in the vaccine group 24,000 adults across six countries Phase 3 placebo-controlled efficacy study Canada Medicago’s p

Do not introduce Digital ID cards, https://petition.parliament.uk/petitions/730194 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea https://www.thefocalpoints.com/p/breaking-second-massive-population https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-025-00831-w Large-scale population-based retrospective study in South Korea To estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data N= 8,407,849 Between 2021 and 2023 Korean National Health Insurance database. The participants were categorized into two groups based on their COVID-19 vaccination status. Cancers significantly increased, 1 year post-vaccination Thyroid HR, 1.351 (95% CI, 1.206–1.514) Gastric HR, 1.335 (95% CI, 1.130–1.576) Colorectal HR, 1.283 (95% CI, 1.122–1.468) Lung HR, 1.533 (95% CI, 1.254–1.874) Breast HR, 1.197 (95% CI, 1.069–1.340) Prostate HR, 1.687 (95% CI, 1.348–2.111) cDNA vaccines Associated with the increased risks of: Thyroid, gastric, colorectal, lung, prostate cancers mRNA vaccines Linked to the increased risks of: Thyroid, colorectal, lung, breast cancers Heterologous vaccination Related to the increased risks of: Thyroid, breast cancers. Observed associations between COVID-19 vaccination and cancer incidence Vaccinated men More vulnerable to gastric and lung cancers Vaccinated women More susceptible to thyroid and colorectal cancers. Population under 65 More vulnerable to thyroid and breast cancers Population over 75 More susceptible to prostate cancer COVID-19 vaccination-associated cancer risk was likely more elevated among individuals aged ≤ 65 (except prostate cancer) Booster doses Gastric and pancreatic cancers Mechanisms from the paper Renin–angiotensin–aldosterone system Mutagenicity Inflammatory cascade Underlying molecular mechanisms And he causeth all, both small and great, rich and poor, free and bond, to receive a mark in their right hand, or in their foreheads: And that no man might buy or sell, save he that had the mark, or the name of the beast, or the number of his name. Here is wisdom. Let him that hath understanding count the number of the beast: for it is the number of a man; and his number is Six hundred threescore and six.

Official UK government report on the debate https://hansard.parliament.uk/commons/2022-10-24/debates/FF880636-BC3B-4BDB-A5E0-D6D4B82B2888/Covid-19VaccinesSafety Official UK Government YouTube channel, the debate in full for those interested https://www.youtube.com/watch?v=pfgGCgxGYkk A few of John’s notes on immunity, from my books, free download site, http://159.69.48.3/ (You will need to cut and past this address into search engine) Acquired or adaptive immunity only develops after there has been contact with a particular antigen. An individual is said to be immune to a particular pathogen when it may be introduced into the body, without causing illness. In contrast to innate immunity, the immune system is changed as a result of exposure to a particular antigen. Acquired immunity is specific to a particular antigen. For example, previous exposure to the measles virus will have allowed the immune system to adapt, generating immunity to any future measles infection. However, because the response is specific, the individual may still suffer from mumps, influenza, or indeed any other antigenic organism it has not previously been exposed to. Antigens (antibody generators) An antigen is anything the immune system recognises as being foreign. When detected, antigens generate an immune response in the body. It is antigens which stimulate the production of antibodies, which are the immune proteins. Usually an antigen is a foreign protein that the body recognises as non-self. The outer coatings of bacteria and viruses contain such foreign proteins. Non-protein large molecules (with a molecular mass of over 1000) will also be antigenic if introduced into the body. So a wide variety of living and non living things can act as antigens; such things are said to possess antigenicity. The specific component of an antigen the immune system recognises as foreign is termed an epitope. Cells involved in adaptive immunity The important classification of white cells involved in adaptive immunity is the small lymphocytes. Small lymphocytes have a large nucleus with only a small area of cytoplasm. In addition to being found in the blood, there are many small lymphocytes in the structures of the lymphatic system, such as the spleen, tonsils and lymph nodes. Small lymphocytes are able to recognise antigenic material, this is essential if they are to mount an immune response. It is estimated that small lymphocytes are capable of producing 100 million different shapes of surface receptors in order to recognise 100 million different forms of antigen. This diversity seems to allow the immune system to recognise all of the possible antigens on the surface of the planet.

Vitamin D supplementation has a protective effect, against the incidence of COVID-19 in RCT studies, OR 0.403, (95% IC 0.218, 0.747) In the RCTs performed on HCWs, the overall reduction in risk in the population supplemented with vitamin D was approximately 80% Against the incidence of COVID-19 in analytical studies OR = 0.592, (95% IC 0.476–0.736) Against the incidence of COVID-19 ICU admission OR 0.317, (95% IC 0.147–0.680). Our meta-analysis suggests a definitive and significant association between the protective role of vitamin D and COVID-19 incidence and ICU admission. Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis https://www.mdpi.com/2072-6643/16/5/679 (28th Feb 2024) Vitamin D, crucial roles Bone homeostasis, muscle function, oncogenesis, immune response and metabolism. In the context of the COVID-19 Numerous researchers have tried to determine the role vitamin D in the immune response to the virus. Systematic review and meta-analysis, 15th May 2023 Preventive vitamin D supplementation, 16 publications N = 1,262,235 participants, A protective role in Incidence of COVID-19 Mortality Admission to intensive care units (ICUs). We calculated the Odds Ratios The assessment of potential bias and the evaluation of study quality will be conducted independently by two researchers. Extra information The majority of the effects of vitamin D are mediated by the VDR, which promotes the expression of genes containing specific DNA sequences and is expressed in almost all nucleated cells Approximately 3 percent of the human genome is under the control of 1,25-dihydroxyvitamin D Vitamin D has been observed to contribute to the synthesis of defensins, to be pivotal for enhancing the phagocytic activity, and to modulate the immune system response by regulating the inflammatory cascade

Link for free download of John's two text books, http://159.69.48.3/ Campbell's Pathophysiology Notes, Amazon orders for the UK, https://www.amazon.co.uk/dp/B012HWC8SU/ref=cm_sw_em_r_mt_dp_AYC5Q7G3H2B3T4BCHQY0 Campbell's Physiology Notes https://www.amazon.co.uk/dp/0955379725/ref=cm_sw_em_r_mt_dp_K0MXMAP26Y77TY4J90FB the disease is mild in almost all of the cases seen so far, Dr Rochelle Walensky, CDC https://www.theguardian.com/world/2021/dec/09/cdc-chief-omicron-mild-early-data-us-spread-variant 75% of US cases vaccinated Scotland, 'tsunami' of Omicron https://www.dailymail.co.uk/news/article-10295867/Omicron-infecting-4-000-BRITONS-day.html Families in Scotland, to self-isolate for 10 days if one member tests positive, regardless of their vaccination status and even if they initially get a negative PCR test UK Government working on a 'Plan C' UK, Health Security Agency https://twitter.com/UKHSA/status/1468951053903142913?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet https://www.gov.uk/government/news/covid-19-variants-identified-in-the-uk Omicron is displaying a significant growth advantage over Delta, likely to outcompete Delta in the UK and become the dominant variant. If the growth rate and doubling time continue, at least 50% of coronavirus (COVID-19) cases to be caused by Omicron variant by mid-December One million by end of December 1% = 10,000 Omicron displays a reduction in protection offered by having had a previous infection or vaccination. There is insufficient data to make any assessment of protection against severe disease, or to assess the severity of illness caused by Omicron. Further studies are underway in the UK and abroad. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039644/Omicron_SGTF_case_update_FINAL.pdf https://www.gov.uk/government/publications/investigation-of-sars-cov-2-variants-technical-briefings Graph refs https://ourworldindata.org/coronavirus SA. Live data, hospital patients who have tested positive https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ South Africa references https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/sars-cov-2-genomic-surveillance-update/ Weekly deaths in SA https://www.samrc.ac.za/reports/report-weekly-deaths-south-africa Variants in SA https://www.worldometers.info/coronavirus/country/south-africa/ https://www.gov.uk/government/publications/sage-98-minutes-coronavirus-covid-19-response-7-december-2021/sage-98-minutes-coronavirus-covid-19-response-7-december-2021 Hospital admissions from Omicron should be expected to follow soon (high confidence). Though there remain some important uncertainties, Early verbal reports indicate that hospitalisations due to Omicron are now increasing in South Africa. The doubling time for new Omicron infections is currently around 3 days in England It is unlikely to be any slower than a 5-day doubling time (high confidence) Household studies show higher secondary attack rates (high confidence). Why is omicron more transmissible? Combinations of transmissibility and immune escape Some early indications from South Africa suggest less severe disease in those hospitalised A modest reduction in severity would not avert high numbers of hospitalisations if growth rates remained very high. One thousand per day be end of month The peak is highly likely to be higher than 1,000 to 2,000 Omicron hospital admissions per day without intervention For it to be below this level there would need to be only a small degree of immune escape and very high protection from boosters against Omicron With very rapid doubling times a large wave could occur leading to synchronous absences from work. With lags of the order of two or more weeks, and doubling times

Dr. Clare Craig’s excellent text on the pandemic, hard copy, Kindle and audio, https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707/ref=sr_1_1?crid=3E93FOWVOC0XX&dib=eyJ2IjoiMSJ9.JFeEViLIDz8rNi6E0HczPLFg-Rhhp0fkaEuFRtYftjRIDahju5qw8l9fofi8C2bD.CDOKUrBi_LzAdqysyTNwiaxvbEegCknK7-KFf6ouAdQ&dib_tag=se&keywords=expired+craig&qid=1758968302&sprefix=expired+craig%2Caps%2C129&sr=8-1 Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ Inside mRNA vaccines https://www.insidemrnavaccines.com/ Filmmaker: Erik Tangsoo Inside the Vaccine Trials https://www.youtube.com/watch?v=tBhjCBa7oDE Inside the vaccine trials https://www.vaccinetrialstories.com/

Official UK government debate https://hansard.parliament.uk/commons/2022-10-24/debates/FF880636-BC3B-4BDB-A5E0-D6D4B82B2888/Covid-19VaccinesSafety Official UK Government YouTube channel, the debate in full for those interested https://www.youtube.com/watch?v=pfgGCgxGYkk Sir Christopher Chope, MP for Christchurch

Covid Inquiry appears fundamentally biased, say scientists 55 professors and academics https://collateralglobal.org/article/an-open-letter-to-baroness-hallett-chair-of-the-uk-covid-inquiry/ https://dailysceptic.org/2024/03/13/covid-inquiry-appears-fundamentally-biased-55-professors-and-academics-tell-baroness-hallett/ https://www.telegraph.co.uk/news/2024/03/12/covid-inquiry-biased-say-scientists/ An open letter to Baroness Hallett, Chair of the UK Covid Inquiry The Inquiry must urgently address its apparent biases, assumptions, impartiality, & lack of evidence-based approach First, the Inquiry gives the impression of being fundamentally biased. there has been little opportunity for petitions to be brought by those who have suffered from the negative effects of pandemic policy decisions. This is preventing a more holistic assessment of impacts on population health and wellbeing. This lack of neutrality appears to have led to biased reasoning and predetermined conclusions, for example, to lockdown faster next time. Second, the Inquiry is taking key assumptions for granted instead of examining and critiquing them in light of the evidence. The consensus position in pre-2020 pandemic plans was that non-pharmaceutical interventions, including lockdown, had weak evidence of effectiveness, and were predicted to cause substantial harm to society, especially if used for prolonged periods. This informed the initial response to Covid in early 2020. Yet, the Inquiry assumes that these measures are effective and appropriate. As a result, it downplays the harms to society caused by two years of emergency infection control mandates. Third, the Inquiry lacks impartiality in the selection and questioning of expert witnesses. It has given preferential treatment to scientific advisers on SAGE, who have a vested interest in maintaining the justification for their policy recommendations. Very few scientists with an alternative position have been asked to testify, and the Inquiry has been confrontational rather than inquisitorial in its questioning of these views. The Inquiry has not seriously questioned the hypotheses and assumptions offered to government, especially from government appointed modelers, which were used to justify Covid policies. Neither has it seriously examined the social and economic costs of lockdown. It has also stuck to an agenda of UK exceptionalism failing to recognize the experience elsewhere in the world. Fourth, the format of the Inquiry is impeding investigation into the key scientific and policy questions. The Inquiry has adopted a legal format that prevents a systematic evaluation of the evidence by biomedical and social scientists on the harms of restrictions to the British public, the impact on Covid from policies such as mandatory NPIs, and the state of evidence for best practice. It is focused on who did or said what, rather than asking fundamental scientific questions. Yet investigating the interplay between harms, benefits, and best practice is critical to preparing for the next pandemic. The Inquiry, as currently functioning, appears unsuited to this task of national importance. Fifth, the Inquiry risks reducing public trust in the impartiality and independence of government accountability and oversight. Its size and cost (by some estimates £300-500 million) will make it the largest public Inquiry ever undertaken to date, and yet its shortcomings, if not addressed, risk compromising the credibility of future public inquiries. We believe the Inquiry has a significant and important mission and we would like to see it succeed. However, if it is to do so, these shortcomings need to be urgently addressed. The Inquiry must invite a much broader range of scientific experts with more critical viewpoints. It must also review the evidence on diverse topics so tha

Omicron emergency https://www.bbc.co.uk/news/uk-59631570 No one should be in any doubt, there is a tidal wave of Omicron coming It is now clear that two doses of vaccine are simply not enough to give the level of protection we all need. But the good news is that our scientists are confident that with a third dose, a booster dose, we can all bring our level of protection back up At this point our scientists cannot say that Omicron is less severe a wave of Omicron through a population that was not boosted would risk a level of hospitalisation that could overwhelm our NHS and lead sadly to very many deaths Aged 18 and over, in England, third jabs from this week Three months since second dose A third booster dose prevents around 75% of people getting any Covid symptoms from Omicron Live data, hospital patients who have tested positive https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ Omicron cases have now been found in hospital Nadhim Zahawi Warned of the danger of tens of thousands of hospitalisations, even if omicron were to prove half as severe as delta SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 31 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1040076/Technical_Briefing_31.pdf Data cut off, 6 December 260 confirmed cases of Omicron VOC-21NOV-01 (B.1.1.529), Identified through sequencing or genotyping in England. Additional possible cases identified through S gene target failure Higher risk of transmission from secondary attack rates Risk of household transmission from an Omicron index case compared to a Delta index case 3.2 Risk of a close contact becoming a secondary case, adjusted odds ratio 2.09 Household secondary attack Omicron, 21.6% Delta, 10.7% Three to eight-fold increased risk of reinfection with the Omicron variant. A 20 to 40-fold reduction in neutralising activity by Pfizer 2-dose vaccinee sera for Omicron At least 10 fold loss of activity when compared to Delta Greater reduction in activity was seen for AZ 2- dose sera An mRNA booster dose resulted in an increase in neutralising activity irrespective of primary vaccination type Data are urgently required on the durability of neutralising activity A moderate to high vaccine effectiveness of 70 to 75% is seen in the early period after a booster dose. With previous variants, vaccine effectiveness against severe disease, has been higher than effectiveness against mild disease Lateral flow, similar sensitivity to detect Omicron compared to Delta Modelling the potential consequences of the Omicron SARS-CoV-2 variant in England https://cmmid.github.io/topics/covid19/omicron-england.html https://www.bbc.co.uk/news/uk-59621029 Growth rate of the Omicron variant Level of immune escape Intrinsic transmissibility Immune escape of Omicron 5.1-fold to 12.8-fold reduction in neutralisation relative to Delta Intrinsic transmissibility Omicron variant is growing in England at an exponential growth rate of r = 0.29 per day This corresponds to a 2.4-day doubling time Reproduction number Rt = 4.0 Generation interval of 5.5 days Surge in SARS-CoV-2 transmission beginning in late December 2021 Infections exceeding peak levels recorded during the January 2021 wave in England The most optimistic scenario, 1 December to 30 April in England Omicron has low immune escape and booster jabs are highly effective 20.9 million infections 175,000 hospital admissions 24,700 deaths Most pessimistic scenario, 1 December and 30 April in England 34.2 million infections 492,000 hospital admissions 74,900 deaths Conclusions and discussion Without the implementation of further control measures, hospital admissions resulting from the Omicron wave of transmiss

Dr. Clare Craig’s excellent text on the pandemic, hard copy, Kindle and audio, https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707/ref=sr_1_1?crid=3E93FOWVOC0XX&dib=eyJ2IjoiMSJ9.JFeEViLIDz8rNi6E0HczPLFg-Rhhp0fkaEuFRtYftjRIDahju5qw8l9fofi8C2bD.CDOKUrBi_LzAdqysyTNwiaxvbEegCknK7-KFf6ouAdQ&dib_tag=se&keywords=expired+craig&qid=1758968302&sprefix=expired+craig%2Caps%2C129&sr=8-1 Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ Inside mRNA vaccines https://www.insidemrnavaccines.com/ Filmmaker: Erik Tangsoo Inside the Vaccine Trials https://www.youtube.com/watch?v=tBhjCBa7oDE Inside the vaccine trials https://www.vaccinetrialstories.com/

Excess deaths AND long-term sickness dramatically increased in the UK New Hope Children's Centre This is a great organisation I have been involved with for 12 years now. I fully attest to the veracity and dedication of all the staff I have met. The founder is Anne Chege, who my brother and I know well. Anne worked with Barclays Bank for 28 years, looking after orphans and abandoned children within her own home. On retirement she opened this centre and has dedicated her life to the work. To contribute to this work, https://www.buymeacoffee.com/newhopechi3 Zoe data https://console.cloud.google.com/storage/browser/covid-public-data Prevalence One in 29 One in 40 (2.43%) Since the end of June 2022, mostly Omicron variant BA.5 Antibodies, 95.8% of adults in England ONS (11th November) https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/deaths Long COVID not main factor in long-term sickness increase 10 November 2022 Since the pandemic in the UK, Number of people out of work because of long-term sickness has risen by around 363,000 The number of people on long-term sick other health problems or disabilities, between April and June 2022, was 97,000 higher than the same period in 2019. A 41% increase UK covid deaths, week ending 28 October 2022 717 deaths involving coronavirus (COVID-19) registered in the UK Previous week, 737 Excess deaths in the UK, ending 28 October 2022 Deaths registered in the UK, 12,861 12.5% above the five-year average (1,430 excess deaths). Deaths involving COVID-19 accounted for 5.6% of all UK deaths UK official data https://coronavirus.data.gov.uk

Long covid seems to be the same as any other post viral syndrome https://www.scimex.org/newsfeed/expert-reaction-long-covid-may-be-no-different-to-other-long-term-virus-effects From: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Queensland data Long COVID ‘indistinguishable’ from other post-viral syndromes and other respiratory virus a year after infection Comparison with influenza and other respiratory illnesses Australia, Queensland, During Omicron wave No evidence of worse post-viral symptoms or functional impairment a year after infection. Long COVID may have appeared to be a distinct and severe illness because of high numbers of COVID-19 cases. N= 5,112 adult symptomatic individuals (Fatigue, brain fog, cough, shortness of breath, change to smell and taste, dizziness, rapid or irregular heartbeat) PCRs conducted between 29 May and 25 June 2022 PCR-confirmed infection for COVID-19 = 2,399 PCR negative for COVID-19 = 2,713 Influenza positive = 995 Results collected, May and June 2023 Overall Still reporting symptoms, 16% (834/5,112) Still reported moderate-to-severe functional impairment, 3.6% (184) Those still reporting any symptoms after a year Post Covid No difference Post Influenza Those with moderate-to-severe functional limitations a year after diagnosis None covid adults, 3% Covid positive adults, 4.1% Influenza positive adults, 3.4% https://bmjpublichealth.bmj.com/content/bmjph/1/1/e000060.full.pdf Comparison at 12 weeks post infection Ongoing symptoms after covid, 21.4% Ongoing symptoms after influenza, 23% Moderate to severe functional impairment after covid, 4.1% Moderate to severe functional impairment after influenza, 4.4% Obvious question not addressed!! Presence of spike protein antibodies Dr John Gerrard, Queensland’s Chief Health Officer These findings underscore the importance of comparing post-COVID-19 outcomes with those following other respiratory infections, and of further research into post-viral syndromes. Furthermore, we believe it is time to stop using terms like ‘long COVID’. They wrongly imply there is something unique and exceptional about longer term symptoms associated with this virus. This terminology can cause unnecessary fear Other commentators https://www.theguardian.com/society/2024/mar/15/long-covid-symptoms-flu-cold https://www.abc.net.au/news/2024-03-16/queensland-chief-health-officer-long-covid/103594020 https://www.9news.com.au/health/coronavirus-australia-queensland-health-study-long-covid/dede1234-d86f-4842-b6f9-975097dc7e62

UK, majority of London cases omicron by tomorrow, Link to free download of my 2 textbooks http://159.69.48.3/ Campbell's Pathophysiology Notes, Amazon orders for the UK, https://www.amazon.co.uk/dp/B012HWC8SU/ref=cm_sw_em_r_mt_dp_AYC5Q7G3H2B3T4BCHQY0 Campbell's Physiology Notes https://www.amazon.co.uk/dp/0955379725/ref=cm_sw_em_r_mt_dp_K0MXMAP26Y77TY4J90FB https://www.youtube.com/watch?v=L9zDnYEgX-U London https://www.youtube.com/watch?v=L9zDnYEgX-U Omicron, 40% of cases Tomorrow, 50% + of cases Boris Johnson At least one UK Omicron death I think the idea that this is somehow a milder version of the virus, I think that’s something we need to set on one side and just recognise the sheer pace at which it accelerates through the population. So the best thing we can do is all get our boosters. Mr Javid https://www.bbc.co.uk/news/live/uk-59632655 Hospitalisations due to large numbers https://www.youtube.com/watch?v=VwyeCeTfiN8 https://www.lbc.co.uk/radio/presenters/tom-swarbrick/south-africa-top-doc-angelique-coetzee-stresses-omicron-mild/ https://www.youtube.com/watch?v=7T0Qiyy854w&t=33s https://www.bbc.co.uk/news/av/uk-59450988 https://metro.co.uk/2021/12/13/south-african-doctor-who-found-omicron-variant-insists-its-mild-15761122/ South Africa https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/covid-19-special-reports/the-initial-and-daily-covid-19-effective-reproductive-number-in-south-africa/ Cyril Ramaphosa, 69, tested positive, Sunday Mild symptoms Louise I am in the Western Cape province in SA where we have just entered our fourth wave, behind other provinces like Gauteng, which seems to have just peaked. Even though our area hasn’t been hit badly by Omicron infections yet, cases are rising quite quickly. Compared to Delta, where you could feel people were very anxious about contracting that variant and almost everyone knew someone in hospital and most knew someone who had died, the mood is definitely different. We are just not hearing about mass hospitalisations like in the third wave and those that are testing positive are mainly feeling flu like symptoms for a few days and then recovering. We are really hopeful that Omicron is definitely much milder. US Cases https://covid.cdc.gov/covid-data-tracker/#trends_dailydeaths Hospitalizations https://covid.cdc.gov/covid-data-tracker/#hospitalizations Pakistan NIH able to confirm … that a recently suspected sample from Karachi is indeed the Omicron variant France Current 5th wave is delta Martin Hirsch, Paris’s AP-HP hospitals group Omicron variant, next month India Very low rates of infection Essential no social distancing Big political rallies Omicron variant, 36 cases 3% of the virus sequences Thailand 3 months to booster after 2nd dose Indonesia Start vaccinations for 6- to 11-year-olds Western Australia Fully reopen borders on 5 February Expected to hit 90% fully vaccinated target Norway https://www.theguardian.com/world/live/2021/dec/13/covid-news-live-boris-johnson-warns-of-omicron-tidal-wave-south-african-president-tests-positive Prime Minister Jonas Gahr Stoere The situation is serious. The spread of infection is too high and we have to take action to limit this development Denmark https://files.ssi.dk/covid19/omikron/statusrapport/rapport-omikronvarianten-12122021-k29d 22nd November to 12 December A total of 2,471 B.1.1.529 (Omicron) SARS-CoV-2 cases in Denmark. Omicron cases are identified through variant PCR and whole-genome sequencing

Henry Ford vaccine study. Senator Ron Johnson’s hearing, titled “How the Corruption of Science has Impacted Public Perception and Policies Regarding Vaccines,” https://live.childrenshealthdefense.org/chd-tv/events/committee-hearings/how-corruption-science-impact-public-perception-policies-vaccines/ After multivariate adjustment 57% of vaccinated children developed at least one chronic health condition (often multiple) 17% of unvaccinated children were chronically ill. Exposure to vaccination was independently associated with an increased risk of developing a chronic health condition (HR 2.53, CI 2.16-2.96). Exposure to vaccination Overall, the development of a chronic health condition occurred more often in the group exposed versus unexposed to vaccination. (p less than 0.0001) IRR 2.48, (CI 2.12-2.91). Risk independently associated with an increased risk of: Asthma HR 4.25, (CI 3.23-5.59) Autoimmune disease HR 4.79, (CI 1.36-16.94) Atopic disease HR 3.03, (CI 2.01-4.57) Eczema HR 1.31, (CI 1.13-1.52) Neurodevelopmental disorder HR 5.53, (CI 2.91-10.51) (mental health and neurodevelopmental disorders including developmental delay and speech disorder) Ear infection IRR 6.63, (CI 5.73-7.66) Chronic ear infection IRR 5.67, (CI 4.37-7.37) Anaphylaxis IRR 8.88, (CI 1.24-63.47) Asthma attack or bronchospasm IRR 6.30, (CI 3.85-10.31) There were no chronic health conditions associated with an increased risk in the unexposed group. Statistical comparisons could not be conducted for certain conditions, such as diabetes and ADHD, because there were no cases in the unexposed group. Ten years of follow up The overall probability of being free of a chronic health condition at 10-years of follow up: 43% in the group exposed to vaccination 83% in the unexposed group. (log-rank test, p less than0.0001) https://www.youtube.com/watch?v=RL5Zx1cIABo https://www.youtube.com/watch?v=Gh6r5rIo4Jw https://live.childrenshealthdefense.org/chd-tv/events/committee-hearings/how-corruption-science-impact-public-perception-policies-vaccines/ Committee on Homeland Security & Governmental Affairs (Search: Henry Ford vaccine study) PDF, entered into hearing records https://childrenshealthdefense.ca/news/henry-ford-birth-cohort-vax-vs-unvax-reveals-staggering-health-risks-in-vaccinated-children/ Impact of Childhood Vaccination on Short and Long-Term Chronic Health Outcomes in Children: A Birth Cohort Study Objective: To compare the short and long-term health outcomes, within a captured payer environment, of children exposed to one or more vaccines to those unexposed. Setting: Integrated healthcare system in Michigan. Participants: 18,468 children born between 2000 and 2016, enrolled in the health system insurance plan. Main Outcome Measures: Development of a chronic health condition over time. Results: 18,468 consecutive subjects 1,957 had no exposure to vaccination 16,511 had received at least one vaccine (various levels of exposure). In exposed subjects, the median number of vaccinations was 18 (IQR 2-28). Conclusion: This study found that exposure to vaccination was independently associated with an overall 2.5-fold increase in the likelihood of developing a chronic health condition, when compared to children unexposed to vaccination. This suggests that in certain children, exposure to vaccination may increase the likelihood of developing a chronic health condition, particularly for one of these conditions.

Covid deaths down 90% in 2022 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---9-november-2022 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/press-briefings Director-General Tedros Adhanom Ghebreyesus 9,400 covid linked deaths last week Almost 90% less than in February of this year (February 2022, 75,000 a week, globally) We have come a long way, and this is definitely cause for optimism. But we continue to call on all governments, communities and individuals to remain vigilant Almost 10,000 deaths a week is 10,000 too many for a disease that can be prevented and treated WHO continues to urge caution, and we continue to urge everyone to be fully vaccinated – including getting your next dose if it’s due. https://www.who.int/westernpacific/emergencies/covid-19/information/transmission-protective-measures Get all the recommended doses of COVID-19 vaccine Keep a safe distance from others, especially in closed spaces When indoors, open windows if possible Wear a mask if you’re or those around you are at high risk of severe illness Keep hands clean Cover coughs and sneezes Stay home when feeling unwel Maria Van Kerkhove substantial underestimate of the true circulation of the virus still a pandemic, and it’s still circulating quite rampantly around the world China, moves towards reality https://www.medscape.com/viewarticle/983898?src=wnl_edit_tpal&uac=127834AR&impID=4860881&faf=1 Shortening quarantine times, close contacts, inbound travellers Seven days down to 5 Stop trying to identify "secondary" contacts Looking incremental National Health Commission (NHC) Optimising and adjusting prevention and control measures Not laying flat 10,535 new domestically transmitted cases for Thursday ONS release, 2nd November 2022 https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/populationandhouseholdestimatesenglandandwales/census2021unroundeddata On Census Day, 21 March 2021, the size of the usual resident population in England and Wales was 59,597,542 56,490,048 in England and 3,107,494 in Wales https://www.gov.uk/government/statistics/patients-registered-at-a-gp-practice-november-2022 https://digital.nhs.uk/data-and-information/publications/statistical/patients-registered-at-a-gp-practice/november-2022 https://digital.nhs.uk/data-and-information/publications/statistical/patients-registered-at-a-gp-practice/november-2022 So Five and a half more people registered with a GP than the total population We also know there are millions in England not registered with a GP Professor Norman Fenton https://twitter.com/profnfenton/status/1591155275272261632/photo/1

And excess deaths and changes in the causes of death. https://twitter.com/ABridgen/status/1769790511475212394 The long term sick has risen by over 700,000 people since the spring of 2021, this coincides with the rollout of the experimental Covid 19 vaccine. https://www.hartgroup.org/rise-in-long-term-sickness/ https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9

Aspiration issue reaches main stream media

Well, this talk was sceduled for about 45 minutes, but ended up at nearly two hours. Link to original video: https://www.youtube.com/watch?v=mkRWsK6U6GA

Thank you GB News and Bev, you made me feel most welcome. Great series of questions. So good to talk face to face rather than via the internet.

John talks with Professor Robert Clancy on the difficulties facing health care and health professionals in Australia and around the world. Direct link to Australian Medical Professionals Society, https://amps.redunion.com.au

Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ Inside mRNA vaccines https://www.insidemrnavaccines.com/ Filmmaker: Erik Tangsoo Inside the Vaccine Trials https://www.youtube.com/watch?v=tBhjCBa7oDE Inside the vaccine trials https://www.vaccinetrialstories.com/

United States to follow. 200,000 new omicron infections per day in the UK now. Zoe study https://covid.joinzoe.com/data#levels-over-time Official UK data https://coronavirus.data.gov.uk/details/cases Boris Johnson UK faces a huge spike in omicron infections https://www.telegraph.co.uk/global-health/science-and-disease/covid-news-vaccine-booster-jab-restrictions-latest-cases-figures/ Mr Javid https://www.gov.uk/government/speeches/health-and-social-care-secretary-oral-statement-on-covid-19 No variant of COVID-19 has spread this fast 4,713 confirmed cases of Omicron in the UK UK Health Security Agency, cases of omicron, + 200,000 per day Over 20% percent of cases in England London, 44% 10 confirmed hospitalised in England with Omicron Hospitalisations and deaths lag infections by around two weeks, dramatically increase in the days and weeks that lie ahead NHS England, return to its highest level of emergency preparedness: Level 4 National Incident. Third dose is 70% percent effective at preventing symptomatic infection COVID, should wait 28 days from their positive result to get their booster Fully vaccinated contacts of a COVID-19 case will now be able to take daily lateral flow tests instead of self-isolating Dr Susan Hopkins, UK Health Security Agency https://www.theguardian.com/world/2021/dec/14/uk-omicron-infections-one-million-a-day-end-december-covid-christmas This is growing very fast with a growth rate of initially two to three days, and that growth rate seems to be shortening rather than lengthening we are going to have a very difficult four weeks ahead Risk of infection, omicron variant, eight times higher than the delta Million cases per day by end of December Professor Graham Medley, infectious disease modelling, London School of Hygiene and Tropical Medicine The number of infections means that even though individually we are at less risk, at population level, the number of people ending up in hospital could get very large Amanda Pritchard, NHS England chief executive, Stephen Powis, NHS Improvement chief executive https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2021/12/C1487-letter-preparing-the-nhs-potential-impact-of-omicron-variant-and-other-winter-pressures-v3.pdf Patients medically fit to be sent home Managing oxygen supplies Increasing critical care capacity Football Manchester United cancelled game Premier league, 42 players positive Professor Chris Whitty Every adult needs to get a booster jab in the face of the highly infectious variant Boosters give you the best possible protection against the virus and should significantly reduce your risk of serious illness and hospitalisation Omicron is spreading across the globe at an unprecedented rate, the World Health Organization https://www.bbc.co.uk/news/world-59656385 https://www.discovery.co.za/corporate/news-room

Association between vitamin D supplementation and COVID-19 infection and mortality https://www.nature.com/articles/s41598-022-24053-4 (12th November 2022) Johns Hopkins University of Michigan National Bureau of Economic Research Department of Medicine, University of Chicago Department of Veterans Health Affairs Department of Medicine, University of Chicago, Chicago Vitamin D deficiency, associated with reduced immune function, can lead to viral infection Vitamin D deficiency, associated, increases the risk of COVID-19 But is it a treatment / prognosis improver? Population of US veterans, we show that Vitamin D2 and D3 fills Associated with reductions in COVID-19 infection After applying all restrictions 220,265 supplemented with vitamin D3 34,710 supplemented with vitamin D2 407,860 untreated patients. Study design Retrospective cohort Supplemented (before and during the pandemic), versus untreated controls One to one matches D2, D3, or calcifediol Veterans Administration Corporate Data Warehouse (CDW) electronic health records. Vitamin D levels typically respond to treatment following two months of exposure D3 cohort COVID-19 rates for the treated = 2.66% COVID-19 rates for the untreated = 3.30% D3 20%, reduction D2 28% reduction Mortality within 30-days of COVID-19 infection Infection ending in mortality within 30 days D3 group Treated group death rate after infection = 0.23% Untreated group death rate after infection = 0.35% Vitamin D3 33% mortality lower (HR, 67%) P  less than  0.001 Vitamin D2 25% lower (HR, 75%) (but not significant) Veterans receiving higher dosages of Vitamin D obtained greater benefits from supplementation than veterans receiving lower dosages. Vitamin D blood levels between 0 and 19 ng/ml, exhibited the largest decrease in COVID-19 infection and mortality following supplementation (0–19 ng/ml, 20–39 ng/ml, and 40 + ng/ml) Dosage options, 20 IU, 40 IU, 100 IU, 125 IU, 200 IU, 250 IU, 400 IU, 500 IU, 800 IU, 1000 IU, 2000 IU, 5000 IU, 8000 IU, and 50,000 IU Black veterans received greater associated COVID-19 risk reductions, with supplementation than White veterans As a safe, widely available, and affordable treatment, Vitamin D may help to reduce the severity of the COVID-19 pandemic. More background Vitamin D insufficiency and deficiency affect approximately half of the US population, with increased rates in people with darker skin, reduced sun exposure, people living in higher latitudes in the winter, nursing home residents, and healthcare workers Populations with low levels of Vitamin D have also experienced higher rates of COVID-19 New mechanism Vitamin D is needed to allow T helper cells to control and reduce Interferon gamma (IFN-γ) production Conclusions These associated reductions in risk are substantial and justify more significant exploration and confirmation using RCTs. This is particularly important given the high rates of vitamin D deficiency in the US population and COVID-19. Extrapolate, D3 supplementation to the entire US population in 2020 4 million fewer COVID-19 cases (19,860,000 actual cases) 116,000 deaths avoided (351,999 actual deaths) Given our findings, the absence of severe side effects, the widespread availability of vitamin D3 at low cost, vitamin D3 presents a unique opportunity to reduce the spread and severity of the COVID-19 pandemic. K2, MK-7 Supplement, probably 100 micrograms per day Nato, 1,000 micrograms per 100 g Cheese, typically 50 micrograms per 100 g Safe and effective UK, GP incentives to vaccinate Home, £30 Standard reimbursement to Primary Care Networks (which then gets passed to GPs) £15 New contract, £12.58 each Lawrence I have heard that Dr. John Campbell is in the pocket of Big Overhead Projector Lobby. Rumour is that he has accepted tens of dollars of under the table e